Edition:
International

Race for a cure Headlines

FILE PHOTO: Moderna could be ready to develop Omicron booster in weeks

Moderna patent fight about feathers, not goose

Moderna’s claim https://investors.modernatx.com/news/news-details/2022/Moderna-Sues-Pfizer-and-BioNTech-for-Infringing-Patents-Central-to-Modernas-Innovative-mRNA-Technology-Platform/default.aspx that the Covid-19 vaccine developed by Pfizer and partner BioNTech used its intellectual property sounds explosive. The sums at stake are potentially huge, as the drug giant estimates sales of the vaccine will be $32 billion this year. It’s in nobody’s interest to kill this golden goose though. The most likely result will simply be lots of legal hissing, and at worst for Pfizer, a few plucked feathers.

COVID-19 vaccination at Glangwili General Hospital in Carmarthen

UK first to approve Omicron COVID shot with Moderna nod

LONDON (Reuters) -Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.

Politics Video

Politics News